COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:

Key Record Dates Identifier: NCT04519476
Brief Title: Selinexor Treatment for Multiple Myeloma Patients Who Are Refractory to Lenalidomide-containing Therapy.

First Submitted : August 12, 2020
First Submitted that Met QC Criteria : August 18, 2020
First Posted : August 19, 2020

Last Update Submitted that Met QC Criteria : October 23, 2020
Last Update Posted : October 27, 2020